Paul Tudor Jones's EHC Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 210,712 shares of Encompass Health Corporation (EHC) worth $26.76 M, representing 0.05% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in EHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 128,191 shares. Largest reduction occurred in Q1 2020, reducing 34,424 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Encompass Health Corporation (EHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Encompass Health Corporation (EHC) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2018 | +9,483 | New Buy | 9,483 | $57.15 |
| Q2 2018 | +30,699 | Add 323.73% | 40,182 | $67.72 |
| Q3 2018 | -40,182 | Sold Out | 40,182 | $0.00 |
| Q4 2018 | +14,984 | New Buy | 14,984 | $61.73 |
| Q1 2019 | +36,113 | Add 241.01% | 51,097 | $58.40 |
| Q2 2019 | -5,818 | Reduce 11.39% | 45,279 | $63.36 |
| Q3 2019 | -45,279 | Sold Out | 45,279 | $0.00 |
| Q1 2020 | +10,855 | New Buy | 10,855 | $64.03 |
| Q2 2020 | -10,855 | Sold Out | 10,855 | $0.00 |
| Q1 2021 | +22,882 | New Buy | 22,882 | $81.90 |
| Q2 2021 | -18,752 | Reduce 81.95% | 4,130 | $77.97 |
| Q3 2021 | +23,525 | Add 569.61% | 27,655 | $75.03 |
| Q4 2021 | -19,051 | Reduce 68.89% | 8,604 | $65.20 |
| Q1 2022 | -8,604 | Sold Out | 8,604 | $0.00 |
| Q1 2023 | +5,683 | New Buy | 5,683 | $0.05 |
| Q2 2023 | -5,683 | Sold Out | 5,683 | $0.00 |
| Q3 2023 | +36,734 | New Buy | 36,734 | $67.16 |
| Q4 2023 | -32,711 | Reduce 89.05% | 4,023 | $66.72 |
| Q1 2024 | -1,254 | Reduce 31.17% | 2,769 | $82.58 |
| Q2 2024 | +9,876 | Add 356.66% | 12,645 | $85.79 |
| Q3 2024 | -10,177 | Reduce 80.48% | 2,468 | $96.64 |
| Q4 2024 | +1,482 | Add 60.05% | 3,950 | $92.35 |
| Q1 2025 | +2,689 | Add 68.08% | 6,639 | $101.28 |
| Q2 2025 | +75,882 | Add 1142.97% | 82,521 | $122.63 |
| Q3 2025 | +128,191 | Add 155.34% | 210,712 | $127.02 |
Paul Tudor Jones's Encompass Health Corporation Investment FAQs
Paul Tudor Jones first purchased Encompass Health Corporation (EHC) in Q1 2018, acquiring 9,483 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Encompass Health Corporation (EHC) for 31 quarters since Q1 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Encompass Health Corporation (EHC) was in Q3 2025, adding 210,712 shares worth $26.76 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 210,712 shares of Encompass Health Corporation (EHC), valued at approximately $26.76 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Encompass Health Corporation (EHC) represents approximately 0.05% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Encompass Health Corporation (EHC) was 210,712 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.